QPharm Pty Ltd
Brisbane, Queensland, 4006, Australia
NCT Number: NCT00996151
The study will evaluate the amount of Testosteron MD-Lotion 2% remaining on the axilla after a single dose application in healthy males who undergo a post dose washing procedure.
Looking for future studies?
Notify Me18 year–70 year
Male
Interventional
Phase 1
Brisbane, Queensland, 4006, Australia
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Single dose Testosterone MD-Lotion 2%
Time frame: March 2010
Time frame: March 2010
Acrux DDS Pty Ltd
Industry
A Healthy Volunteer, Single Dose Phase I Trial to Determine the Amount of Testerone MD-Lotion 2% Remaining on the Axilla After Washing.
Acronym: MTE11
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06280807
Amenorrhea, Endocrine System Diseases
Research Triangle Park, North Carolina, United States
View Trial Details